by Dr. Peter McCullough,Global Research:
Dr. Peter McCullough with Amber May reveals the life-saving potential of repurposed anti-parasitics and the path to true detoxification.
In this episode of The Amber May Show, host Amber May interviewsDr. Peter McCullough, Chief Scientific Officer of The Wellness Company, to discuss innovative, repurposed treatments for cancer and detoxification protocols for those affected by SARS-CoV-2 and COVID-19 vaccines.
TRUTH LIVES on athttps://sgtreport.tv/
Dr. McCullough highlights recent observational research conducted by theMcCullough FoundationandThe Wellness Companyregarding the off-label use ofIvermectinandMebendazoleas adjunctive cancer therapies. He explains that these generic anti-infectives exhibit antineoplastic properties—specifically reducing tumor proliferation, inhibiting angiogenesis, and promoting apoptosis. The study showed promising outcomes, with patients reporting high rates of remission maintenance, stabilized active cancer, and occasional regression, alongside acceptable safety profiles.
Dr. McCullough argues that the “medical-industrial complex” and the “book and bill” paradigm in cancer centers—which incentivize the use of expensive, proprietary chemotherapy—hinder the routine adoption of low-cost generic alternatives. He expresses frustration over the slow pace of institutional validation and calls for large-scale, prospective, randomized, placebo-controlled trials to verify these signals.
The conversation pivots to the persistent health risks posed by the spike protein from both SARS-CoV-2 infection and mRNA vaccines. Dr. McCullough clarifies that while the body does not “replicate” the vaccine’s mRNA, the spike protein remains a systemic danger. He outlines a core detoxification protocol for exposed individuals, which includes:
Source: SGT Report
